{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:33:17Z","timestamp":1791462797156,"version":"4.3.4"},"reference-count":83,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T00:00:00Z","timestamp":1589068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI114806"],"award-info":[{"award-number":["AI114806"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Quinoline-based scaffolds have been the mainstay of antimalarial drugs, including many artemisinin combination therapies (ACTs), over the history of modern drug development. Although much progress has been made in the search for novel antimalarial scaffolds, it may be that quinolines will remain useful, especially if very potent compounds from this class are discovered. We report here the results of a structure-activity relationship (SAR) study assessing potential unsymmetrical bisquinoline antiplasmodial drug candidates using in vitro activity against intact parasites in cell culture. Many unsymmetrical bisquinolines were found to be highly potent against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum parasites. Further work to develop such compounds could focus on minimizing toxicities in order to find suitable candidates for clinical evaluation.<\/jats:p>","DOI":"10.3390\/molecules25092251","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T02:41:20Z","timestamp":1589251280000},"page":"2251","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Unsymmetrical Bisquinolines with High Potency against P. falciparum Malaria"],"prefix":"10.3390","volume":"25","author":[{"given":"Katherine M.","family":"Liebman","sequence":"first","affiliation":[{"name":"DesignMedix, Inc., Portland, OR 97201, USA"},{"name":"Department of Chemistry, Portland State University, Portland, OR 97207, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Burgess","sequence":"additional","affiliation":[{"name":"DesignMedix, Inc., Portland, OR 97201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bornface","family":"Gunsaru","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Portland State University, Portland, OR 97207, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane X.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Portland State University, Portland, OR 97207, USA"},{"name":"Portland VA Research Foundation, Portland, OR 97239, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexin","family":"Li","sequence":"additional","affiliation":[{"name":"Portland VA Research Foundation, Portland, OR 97239, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Westin","family":"Morrill","sequence":"additional","affiliation":[{"name":"DesignMedix, Inc., Portland, OR 97201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Liebman","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Portland State University, Portland, OR 97207, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5828-055X","authenticated-orcid":false,"given":"David H.","family":"Peyton","sequence":"additional","affiliation":[{"name":"DesignMedix, Inc., Portland, OR 97201, USA"},{"name":"Department of Chemistry, Portland State University, Portland, OR 97207, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,10]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2016). World Malaria Report 2016, World Health Organization Press."},{"key":"ref_2","unstructured":"World Health Organization (WHO) (2019). World Malaria Report 2019, World Health Organization Press."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Menard, D., and Dondorp, A. (2017). Antimalarial Drug Resistance: A Threat to Malaria Elimination. Cold Spring Harb. Perspect. Med., 7.","DOI":"10.1101\/cshperspect.a025619"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Nsanzabana, C. (2019). Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug!. Trop. Med. Infect. Dis., 4.","DOI":"10.3390\/tropicalmed4010026"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.chom.2019.06.001","article-title":"Elucidating Mechanisms of Drug-Resistant Plasmodium falciparum","volume":"26","author":"Ross","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2165\/11203910-000000000-00000","article-title":"Dihydroartemisinin\/Piperaquine: A review of its use in the treatment of uncomplicated Plasmodium falciparum malaria","volume":"72","author":"Keating","year":"2012","journal-title":"Drugs"},{"key":"ref_7","unstructured":"World Health Organization (2015). Guidelines for the Treatment of Malaria, World Health Organization. [3rd ed.]."},{"key":"ref_8","unstructured":"Au, B. (1962). Nouveaux D\u00e9riv\u00e9s de la Quinol\u00e9ine et Leur Pr\u00e9paration. (FR84902), France Patent."},{"key":"ref_9","first-page":"459","article-title":"Plasmodium berghei and prolonged-action antimalarials","volume":"45","author":"Benazet","year":"1965","journal-title":"Ann. Soc. Belges. Med. Trop. Parasitol. Mycol."},{"key":"ref_10","first-page":"435","article-title":"Plasmodium berghei and chemotherapy","volume":"45","author":"Schneider","year":"1965","journal-title":"Ann. Soc. Belges. Med. Trop. Parasitol. Mycol."},{"key":"ref_11","unstructured":"Brevent (1963). Nouveaux d\u00e9riv\u00e9s de la quinol\u00e9ine et leur pr\u00e9paration. (BE633453), Belgium Patent."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2049-9957-3-9","article-title":"Development of antimalarial drugs and their application in China: A historical review","volume":"3","author":"Chen","year":"2014","journal-title":"Infect. Dis. Poverty"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-200565010-00004","article-title":"Piperaquine: A resurgent antimalarial drug","volume":"65","author":"Davis","year":"2005","journal-title":"Drugs"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/cmdc.200600240","article-title":"Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development","volume":"2","author":"Schlitzer","year":"2007","journal-title":"Chem. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.bcp.2007.03.011","article-title":"Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases","volume":"73","author":"Warhurst","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"ref_16","first-page":"281","article-title":"Field observations on the antimalarial piperaquine","volume":"95","author":"Chen","year":"1982","journal-title":"Chin. Med. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/cbdd.12914","article-title":"Design, synthesis and in vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain","volume":"89","author":"Kondaparla","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"25596","DOI":"10.1074\/jbc.M503227200","article-title":"Dictyostelium discoideum expresses a malaria chloroquine resistance mechanism upon transfection with mutant, but not wild-type, Plasmodium falciparum transporter PfCRT","volume":"280","author":"Naude","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1021\/jm00089a025","article-title":"Bisquinolines. 1. N,N-bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria","volume":"35","author":"Vennerstrom","year":"1992","journal-title":"J. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/AAC.47.4.1391-1394.2003","article-title":"In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon","volume":"47","author":"Basco","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijpddr.2018.05.003","article-title":"Longitudinal surveillance of drug resistance in Plasmodium falciparum isolates from the China-Myanmar border reveals persistent circulation of multidrug resistant parasites","volume":"8","author":"Bai","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lon, C., Manning, J.E., Vanachayangkul, P., So, M., Sea, D., Se, Y., Gosi, P., Lanteri, C., Chaorattanakawee, S., and Sriwichai, S. (2014). Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: An open-label randomized trial. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0093138"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: A prospective clinical, pharmacological, and genetic study","volume":"19","author":"Imwong","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/bfgp\/elz008","article-title":"The genomic architecture of antimalarial drug resistance","volume":"18","author":"Cowell","year":"2019","journal-title":"Brief. Funct. Genom."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1128\/AAC.00183-10","article-title":"Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum","volume":"54","author":"Briolant","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1128\/AAC.01793-10","article-title":"Piperaquine resistance is associated with a copy number variation on chromosome 5 in drug-pressured Plasmodium falciparum parasites","volume":"55","author":"Eastman","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1128\/AAC.02306-12","article-title":"In vitro sensitivities of Plasmodium falciparum isolates from the China-Myanmar border to piperaquine and association with polymorphisms in candidate genes","volume":"57","author":"Hao","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/1475-2875-12-431","article-title":"In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene","volume":"12","author":"Pascual","year":"2013","journal-title":"Malar. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1038\/s41467-018-05652-0","article-title":"Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine","volume":"9","author":"Ross","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/jo502511j","article-title":"Mono- and Bisquinoline-Annulated Porphyrins from Porphyrin beta,beta\u2019-Dione Oximes","volume":"80","author":"Akhigbe","year":"2015","journal-title":"J. Org. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4269\/ajtmh.1994.50.200","article-title":"In vitro activity of bisquinoline WR268,668 against African clones and isolates of Plasmodium falciparum","volume":"50","author":"Basco","year":"1994","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_32","first-page":"170","article-title":"Progress in malaria chemotherapy. 1. Repository antimalarial drugs","volume":"13","author":"Elslager","year":"1969","journal-title":"Prog. Drug. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0020-7519(98)00217-3","article-title":"Bisquinoline antimalarials: Their role in malaria chemotherapy","volume":"29","author":"Raynes","year":"1999","journal-title":"Int. J. Parasitol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0006-2952(96)00306-1","article-title":"Novel bisquinoline antimalarials. Synthesis, antimalarial activity, and inhibition of haem polymerisation","volume":"52","author":"Raynes","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1128\/AAC.41.3.677","article-title":"Antimalarial activity of the bisquinoline trans-N1,N2-bis (7-chloroquinolin-4-yl)cyclohexane-1,2-diamine: Comparison of two stereoisomers and detailed evaluation of the S,S enantiomer, Ro 47\u20137737","volume":"41","author":"Ridley","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2012.07.037","article-title":"Synthesis and in vitro antimalarial activity of a series of bisquinoline and bispyrrolo[1,2a]quinoxaline compounds","volume":"55","author":"Cloete","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1021\/jm9803828","article-title":"Bisquinolines. 2. Antimalarial N,N-bis(7-chloroquinolin-4-yl)heteroalkanediamines","volume":"41","author":"Vennerstrom","year":"1998","journal-title":"J. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/jm001096a","article-title":"Antiplasmodial activity and cytotoxicity of bis-, tris-, and tetraquinolines with linear or cyclic amino linkers","volume":"44","author":"Girault","year":"2001","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1021\/jm990946n","article-title":"Antimalarial, antitrypanosomal, and antileishmanial activities and cytotoxicity of bis(9-amino-6-chloro-2-methoxyacridines): Influence of the linker","volume":"43","author":"Girault","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1021\/jm020960r","article-title":"Synthesis and in vitro and in vivo antimalarial activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives","volume":"46","author":"Ryckebusch","year":"2003","journal-title":"J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0006-2952(97)00509-1","article-title":"A Comparison and Analysis of Several Ways to Promote Haematin (Haem) Polymerisation and an Assessment of Its Initiation In Vitro","volume":"55","author":"Dorn","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(97)00510-8","article-title":"An Assessment of Drug-Haematin Binding as a Mechanism for Inhibition of Haematin Polymerisation by Quinoline Antimalarials","volume":"55","author":"Dorn","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1015602002694","article-title":"Crystal structure of the potent bisquinoline antimalarial agent (+\/\u2212)-trans-N-1,N-2-bis(7-chloroquinolin-4-yl) cyclohexane-1,2-diamine dimethanesulfonate salt hydrate in relation to its biological properties","volume":"32","author":"Karle","year":"2002","journal-title":"J. Chem. Crystallogr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/00034983.1997.11813174","article-title":"Haematin (haem) polymerization and its inhibition by quinoline antimalarials","volume":"91","author":"Ridley","year":"1997","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_45","unstructured":"Brevent (1962). Nouveaux d\u00e9riv\u00e9s de la quinol\u00e9ine et leur pr\u00e9paration. (BE612207), Belgium Patent."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1021\/jm1006484","article-title":"Synthesis, structure-activity relationship, and mode-of-action studies of antimalarial reversed chloroquine compounds","volume":"53","author":"Burgess","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2174\/156802612799362968","article-title":"Reversed chloroquine molecules as a strategy to overcome resistance in malaria","volume":"12","author":"Peyton","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_48","unstructured":"Burgess, S.J. (2008). Design and Synthesis of Antimalarial Drugs Based on a Chloroquine Scaffold, Eds, ProQuest Limited Liability Company, Portland State University."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/bchm2.1942.274.1-6.1","article-title":"\u00dcber die Bedeutung der chinoiden Bindung in Chinolinverbindungen f\u00fcr die Malariawirkung","volume":"274","year":"1942","journal-title":"Hoppe-Seyler\u2019s Zeitschrift f\u00fcr Physiologische Chemie"},{"key":"ref_50","unstructured":"Wiselogle, F.Y. (1946). A Survey of Antimalarial Drugs, 1941\u20131945, J. W. Edwards."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/cber.19480810607","article-title":"Antimalariamittel aus der Gruppe halogensubstituierter Chinolinverbindungen","volume":"81","author":"Andersag","year":"1948","journal-title":"Chem. Ber."},{"key":"ref_52","first-page":"1","article-title":"Survey of antimalarial agents: Chemotherapy of Plasmodium gallinaceum infections; toxicity; correlation of structure and action","volume":"9","author":"Coatney","year":"1953","journal-title":"Public Health Monogr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF01471547","article-title":"Trends of progress in chemotherapy","volume":"29","author":"Mietzsch","year":"1951","journal-title":"Klin. Wochenschr."},{"key":"ref_54","first-page":"1219","article-title":"Antimalarial 6-aminoquinolines XV. 6- and 4-aminoquinolines with a tertiary basic alkylated amino group. Gegen Malaria wirksame 6-Aminochinoline","volume":"32","author":"Dann","year":"1982","journal-title":"Arzneimittel-Forsch."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1021\/jm990437l","article-title":"Structure-function relationships in aminoquinolines: Effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/BJ20060986","article-title":"The role of neutral lipid nanospheres in Plasmodium falciparum haem crystallization","volume":"402","author":"Pisciotta","year":"2007","journal-title":"Biochem. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.molbiopara.2007.11.005","article-title":"Haemozoin formation","volume":"157","author":"Egan","year":"2008","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1021\/cg4009416","article-title":"Synthetic Hemozoin (beta-Hematin) Crystals Nucleate at the Surface of Neutral Lipid Droplets that Control Their Sizes","volume":"13","author":"Ambele","year":"2013","journal-title":"Cryst. Growth. Des."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1021\/jm900972u","article-title":"Reversal agent and linker variants of reversed chloroquines: Activities against Plasmodium falciparum","volume":"53","author":"Andrews","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.bmcl.2004.12.037","article-title":"Synthesis of ring-substituted 4-aminoquinolines and evaluation of their antimalarial activities","volume":"15","author":"Madrid","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1071\/CH9930021","article-title":"Potential Antimalarials. XVII. Di- and Mono-Mannich Bases of 2(and 4)-[2(and 8)-Trifluoromethylquinolin-4-ylamino]phenol","volume":"46","author":"Barlin","year":"1993","journal-title":"Aust. J. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1071\/CH9851827","article-title":"Potential Antimalarials. V. 4-(7\u2032-Trifluoromethylquinolin-4\u2032-Ylamino)Phenols, 4-[2\u2032,7\u2032 and 2\u2019,8\u2032-Bis(Trifluoromethyl)Quinolin-4\u2032-Ylamino]Phenols and N4-Substituted 2,7-(and 2,8-)Bis(Trifluoromethyl)-Quinolin-4-Amines","volume":"38","author":"Barlin","year":"1985","journal-title":"Aust. J. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1002\/chem.201605099","article-title":"Modulation of Antimalarial Activity at a Putative Bisquinoline Receptor In Vivo Using Fluorinated Bisquinolines","volume":"23","author":"Fielding","year":"2017","journal-title":"Chemistry"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1021\/jm801352s","article-title":"Combining 4-aminoquinoline- and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarials","volume":"52","author":"Gemma","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2174\/157340608785700216","article-title":"N,N-Bis(trifluoromethylquinolin-4-yl)diamino alkanes: Synthesis and antimalarial activity","volume":"4","author":"Kgokong","year":"2008","journal-title":"Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1021\/jm9902180","article-title":"Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth","volume":"42","author":"Vippagunta","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1016\/j.bmc.2007.07.012","article-title":"Metallocene-based antimalarials: An exploration into the influence of the ferrocenyl moiety on in vitro antimalarial activity in chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum","volume":"15","author":"Blackie","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4269\/ajtmh.1996.55.579","article-title":"Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro","volume":"55","author":"De","year":"1996","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1021\/jm020858u","article-title":"Structure-activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position","volume":"45","author":"Kaschula","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1021\/jm301654b","article-title":"N-cinnamoylated chloroquine analogues as dual-stage antimalarial leads","volume":"56","author":"Perez","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1021\/jm201676t","article-title":"Design, synthesis, and in vitro activity of novel 2\u2019-O-substituted 15-membered azalides","volume":"55","author":"Pesic","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1021\/acs.jmedchem.5b01374","article-title":"Reinvestigating Old Pharmacophores: Are 4-Aminoquinolines and Tetraoxanes Potential Two-Stage Antimalarials?","volume":"59","author":"Terzic","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/00034983.1982.11687540","article-title":"The chemotherapy of rodent malaria XXXIII. The activity of chloroquine and related blood schizontocides and of some analogues in drug-induced pigment clumping","volume":"76","author":"Warhurst","year":"1982","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1021\/jm980146x","article-title":"Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines","volume":"41","author":"De","year":"1998","journal-title":"J. Med. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jlac.18972970102","article-title":"Untersuchungen \u00fcber die Oxymethylenverbindungen. (Zweite Abhandlung.)","volume":"297","author":"Claisen","year":"1897","journal-title":"Justus Liebig\u2019s Annalen der Chemie"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1021\/ja01211a020","article-title":"The synthesis of 4-hydroxyquinolines; through ethoxymethylene malonic ester","volume":"68","author":"Price","year":"1946","journal-title":"J. Am. Chem. Soc."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1021\/ja01265a088","article-title":"The Synthesis of Certain Substituted Quinolines and 5,6-Benzoquinolines","volume":"61","author":"Gould","year":"1939","journal-title":"J. Am. Chem. Soc."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/jhet.5570330233","article-title":"Synthesis of azolylalkylquinolines with cytotoxic activity","volume":"33","author":"Abel","year":"1996","journal-title":"J. Heterocyclic. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1021\/jm901184n","article-title":"Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydro benzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: Potent in vivo activity in Parkinson\u2019s disease animal models","volume":"53","author":"Ghosh","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1021\/ja01150a060","article-title":"The Role of Phenol in the Reaction of 4,7-Dichloroquinoline with Novol Diamine","volume":"73","author":"Surrey","year":"1951","journal-title":"J. Am. Chem. Soc."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1248\/cpb.42.2276","article-title":"Amphoteric drugs. I. Synthesis and antiallergic activity of [4-(diphenylmethoxy)piperidino]-, [4-(diphenylmethyl)piperazinyl]- and [4-(diphenylmethylene)piperidino]alkanoic acid derivatives","volume":"42","author":"Iwasaki","year":"1994","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1021\/jm060399n","article-title":"A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum","volume":"49","author":"Burgess","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/9\/2251\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:27:26Z","timestamp":1760174846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/9\/2251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,10]]},"references-count":83,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["molecules25092251"],"URL":"https:\/\/doi.org\/10.3390\/molecules25092251","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,10]]}}}